SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ken Crooks who wrote (329)9/25/1997 11:52:00 PM
From: Ted Gregg   of 834
 
Texas Biotechnology/Pricing -2: Lehman Is Lead Underwriter

NEW YORK (Dow Jones)--An offering of 5 million common shares of Texas Biotechnology Corp. (TXB) was priced at $5 each through underwriters led by Lehman Brothers Inc.

Gross spread is 30 cents, selling concession is 15 cents and reallowance is 10 cents. Delivery is scheduled for October 1.

Proceeds from the offering are expected to be used for general corporate purposes.

"Dow Jones News Service"
"Copyright(c) 1997, Dow Jones & Company, Inc."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext